Key takeaways:
- Sufferers can now accumulate cervical most cancers screening samples themselves, at dwelling.
- Producers of the brand new system say it’s as correct as conventional screening strategies.
The FDA has accredited the primary and solely self-collection cervical most cancers screening system, the place sufferers can acquire their very own samples from the consolation of their very own dwelling.
The Teal Wand, manufactured by Teal Well being, is an alternative choice to the normal methodology, which might be uncomfortable and inconvenient, in response to a press launch from Teal Well being.

The FDA has accredited a novel cervical most cancers screening system that permits sufferers to gather their very own pattern at dwelling.
“Cervical most cancers is essentially preventable, but screening charges within the U.S. proceed to lag, and the FDA approval of this at-home Teal Wand self-collection system is a important step ahead,” Christine Conageski, MD, MSc, an affiliate professor of obstetrics and gynecology and director of the Advanced Dysplasia Clinic on the College of Colorado, and a principal investigator within the product’s trial, stated within the launch. “It presents an evidence-based solution to develop entry with out compromising accuracy.”
The Teal Wand exams a pattern for HPV, which causes most cervical cancers, and it makes use of the identical guideline-recommended check that suppliers use within the clinic; it “merely supplies a unique methodology of pattern assortment,” in response to the discharge. The at-home screening course of contains the Teal Wand assortment package and a telehealth service that gives digital entry to Teal medical suppliers who help sufferers all through the method, together with by prescribing the package and reviewing the lab outcomes.
“Entry is barely a part of the answer. Complete screening should go hand in hand with structured, dependable follow-up. That’s why Teal Well being’s method to not solely advancing screening expertise but in addition offering training and help to girls by each step of their care and follow-up journey is essential,” Conageski stated. “That’s how we guarantee this breakthrough actually closes the hole.”
The prescription system will quickly be accessible on-line for these aged 25 to 65 years and at common threat for cervical most cancers. In keeping with the discharge, kits will develop into accessible in California in June and develop nationally later.
As for value, “Teal is working with main insurance coverage suppliers and plans to have versatile cost choices, serving to to take away monetary issues and making certain extra girls have entry to this most well-liked at-home screening if they need it,” in response to the discharge.
The American Most cancers Society applauded the approval.
“Regardless of the advantages of cervical most cancers screening, not all eligible are screened often,” William L. Dahut, MD, chief scientific officer on the American Most cancers Society, stated in an announcement. “Most cervical cancers are present in individuals who have by no means had a cervical most cancers screening check or who haven’t had one lately. That is why at present’s Meals and Drug Administration’s announcement approving the primary at-home check to display for cervical most cancers as a further most cancers screening methodology for this probably lethal illness will make a big impact.”